BEAM THERAPEUTICS INC shareholders Q2 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$90,850,00040.87%
Deep Track Capital, LP 1,250,000$48,388,0003.18%
HSG Holding Ltd 796,089$30,817,0002.84%
Redmile Group, LLC 1,849,887$71,609,0002.73%
ARK Investment Management 8,792,064$309,305,0001.83%
Evolutionary Tree Capital Management, LLC 31,893$1,235,0001.34%
BRANDYWINE MANAGERS, LLC 13,067$506,0001.24%
Casdin Capital, LLC 375,000$14,516,0001.23%
Temasek Holdings (Private) Ltd 3,959,212$153,261,0970.84%
Yiheng Capital Management, L.P. 363,800$14,083,0000.80%
FARALLON CAPITAL MANAGEMENT LLC 3,472,271$134,412,0000.73%
Alphabet Inc. 321,604$12,449,0000.68%
HighVista Strategies LLC 20,980$812,0000.49%
Capital Impact Advisors, LLC 8,931$346,0000.32%
Bellevue Group AG 572,621$22,166,0000.31%
Baker Chad R 27,550$1,067,0000.30%
Eagle Health Investments LP 28,900$1,119,0000.26%
KRAEMATON INVESTMENT ADVISORS, INC 5,515$213,0000.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 910$23,500,0000.24%
Graham Capital Management, L.P. 135,588$5,248,0000.21%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q2 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.